Intérêt et limites de la détermination de l’activité enzymatique de l’α-galactosidase A dans les populations à risque pour la maladie de Fabry
Med Sci (Paris), 21 (2005) 53-54
Published online: 2005-11-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Diminished bile acids excretion is a risk factor for coronary artery disease: 20-year follow up and long-term outcome
Gideon Charach, Ori Argov, Karyn Geiger, Lior Charach, Ori Rogowski and Itamar GrosskopfTherapeutic Advances in Gastroenterology 11 (2018)
https://doi.org/10.1177/1756283X17743420
A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance
L van der Tol, B E Smid, B J H M Poorthuis, et al.Journal of Medical Genetics 51 (1) 1 (2014)
https://doi.org/10.1136/jmedgenet-2013-101857
The Role of Bile Acid Excretion in Atherosclerotic Coronary Artery Disease
Gideon Charach, Alexander Rabinovich, Ori Argov, Moshe Weintraub and Pavel RabinovichInternational Journal of Vascular Medicine 2012 1 (2012)
https://doi.org/10.1155/2012/949672
La maladie de Fabry : de la découverte des lysosomes à l’avènement de la thérapeutique
Dominique P. Germainmédecine/sciences 21 5 (2005)
https://doi.org/10.1051/medsci/20052111s5